Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

MSc Personalised Medicine and Novel Therapies and MSc Cell and Gene Therapy | Information Session

Flexible manufacturing strategies for cell and gene therapy products

The Future of CDMO Networks in Cell and Gene Therapy

Stem Cell and Gene Therapy - Matthew Porteus, Tippi Mackenzie, Matthew Spear, Stephen Gottschalk

Panel: Alternative IPO Strategies for Cell and Gene Therapy Companies

Introducing the Cell and Gene Therapy Catapult’s Process Analytical Technologies Laboratory

Site Design Considerations for Cell and Gene Therapy Commercial Facilities

Crispr Therapeutics: Will radio-pharma impact Car-T for oncology?

Panel: What Cell & Gene Therapy Investors Are Looking for Now

Panel: Next Generation Cell and Gene Therapy in Oncology

CliniMACS Prodigy® Adherent Cell Culture System: Automated, large-scale, and GMP-compliant

ElevateBio CEO on disruptive potential for gene and cell therapies

Plenary Session: Gene Therapy & Gene-Modified Cell Therapies

Panel: Alternate IPO Strategies fo Cell and Gene Therapy Companies

Cell and gene therapy validation challenges

Scaling Gene & Cell Therapies to Reach More Patients Globally

GMP requirements for cell and gene therapy institutions-20201112 0600-1

A view on streamlining the Cell and Gene Therapy manufacturing

BIA Webinar: Advances in Cell and Gene Therapy